Thermo Fisher Scientific (TMO) Short-Term Debt issuances (2009 - 2026)

Thermo Fisher Scientific has reported Short-Term Debt issuances for 17 years, with the latest figure at $389.0 million in Q1 2026.

• Short-Term Debt issuances for Q1 2026 came in at $389.0 million, changed N/A year-over-year; the trailing twelve-month figure through Jun 2026 was $1.5 billion (changed N/A YoY), and the FY2025 annual result was $1.1 billion, changed N/A from the prior year.
• Short-Term Debt issuances retreated to $389.0 million in Q1 2026, from $1.1 billion in the prior quarter.
• Over five years, Short-Term Debt issuances peaked at $2.2 billion in Q3 2022 and troughed at $200.0 million in Q4 2022.
• A 4-year average of $888.6 million and a median of $810.0 million in 2023 frame the typical range for Short-Term Debt issuances.
• The largest YoY upside for Short-Term Debt issuances was 57.5% in 2023 against a maximum downside of 73.42% in 2023.
• A 4-year view of Short-Term Debt issuances shows it stood at $200.0 million in 2022, then jumped by 57.5% to $315.0 million in 2023, then jumped by 247.62% to $1.1 billion in 2025, then slumped by 64.47% to $389.0 million in 2026.
• Per Business Quant data, the three most recent Short-Term Debt issuances figures were $389.0 million in Q1 2026, $1.1 billion in Q3 2025, and $315.0 million in Q3 2023.